enGene Holdings Inc.
ENGN · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $369,907 | $193,660 | $211,219 | $341,546 |
| - Cash | $50,152 | $32,623 | $57,545 | $62,346 |
| + Debt | $31,795 | $31,377 | $25,360 | $25,133 |
| Enterprise Value | $351,550 | $192,414 | $179,034 | $304,333 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$171 | -$130 | -$106 | -$102 |
| % Margin | – | – | – | – |
| EBITDA | -$37,456 | -$27,864 | -$24,735 | -$23,744 |
| % Margin | – | – | – | – |
| Net Income | -$37,880 | -$28,991 | $25,815 | -$24,616 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.74 | -0.57 | 0.51 | -0.48 |
| % Growth | -29.8% | -211.8% | 206.3% | – |
| Operating Cash Flow | -$24,962 | -$25,634 | -$22,947 | -$25,696 |
| Capital Expenditures | -$437 | -$704 | -$45 | -$299 |
| Free Cash Flow | -$25,399 | -$26,338 | -$22,992 | -$25,995 |